Original Research

Published on 29 Mar 2023

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

in Hematologic Malignancies

Andrea Duminuco
Alessandra Romano
Dario Leotta
Enrico La Spina
Daniela Cambria
Anna Bulla
Vittorio Del Fabro
Daniele Tibullo
Cesarina Giallongo
Giuseppe A. Palumbo

Frontiers in Oncology

doi 10.3389/fonc.2023.1157610

1,755 views
4 citations

Case Report

Published on 29 Mar 2023

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

in Hematologic Malignancies

Luomengjia Dai
Han Zhang
Wen Chen
Yi Xia
Shuchao Qin
Yang Shao
Jianyong Li
Yi Miao
Bingzong Li
Huayuan Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1145376

1,545 views

Original Research

Published on 28 Mar 2023

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis

in Hematologic Malignancies

Zhentian Wu
Chenyi Wang
Yao Lyu
Zheshen Lin
Ming Lu
Shixiong Wang
Bingxuan Wang
Na Yang
Yeye Li
Jianhong Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1104425

2,241 views
2 citations

Original Research

Published on 28 Mar 2023

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

in Hematologic Malignancies

Youngwoo Jeon
Duk-Hwan Yang
Suk-Joong Oh
Jin-Hee Park
Jung-Ah Kim
Sung-Young Kim
Chul-Won Choi
Won-Sik Lee
In-Ho Kim
Yeung-Chul Mun

Frontiers in Oncology

doi 10.3389/fonc.2023.998014

1,711 views
1 citation

Editorial

Published on 28 Mar 2023

Editorial: Advances in the understanding and treatment of cutaneous lymphoma

in Hematologic Malignancies

Andrea Bernardelli
Lorenzo Falchi
Jianjun Qiao
Carlo Visco

Frontiers in Oncology

doi 10.3389/fonc.2023.1190269

1,000 views

Original Research

Published on 27 Mar 2023

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

in Hematologic Malignancies

Mariarita Sciumè
Alessandro Bosi
Marta Canzi
Giusy Ceparano
Fabio Serpenti
Pasquale De Roberto
Sonia Fabris
Elena Tagliaferri
Francesca Cavallaro
Francesco Onida

Frontiers in Oncology

doi 10.3389/fonc.2023.1149298

2,559 views
3 citations

Case Report

Published on 27 Mar 2023

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

in Hematologic Malignancies

Yuan Ren
Congwei Jia
Miao Chen
Wei Wang
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1170598

2,019 views

Review

Published on 24 Mar 2023

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma

in Hematologic Malignancies

Marion Lacroix
Hugues Beauchemin
Cyrus Khandanpour
Tarik Möröy

Frontiers in Oncology

doi 10.3389/fonc.2023.1148936

4,626 views
3 citations

Editorial

Published on 24 Mar 2023

Editorial: Inflammation and blood diseases, a dog chasing its tail

in Hematologic Malignancies

Cosimo Cumbo
Francesco Tarantini
Michele Gottardi
Francesco Albano

Frontiers in Oncology

doi 10.3389/fonc.2023.1180559

759 views

Editorial

Published on 23 Mar 2023

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies

in Hematologic Malignancies

Andreas Agathangelidis
Manlio Ferrarini
Franco Fais

Frontiers in Oncology

doi 10.3389/fonc.2023.1188375

686 views

Original Research

Published on 23 Mar 2023

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT

in Hematologic Malignancies

Zhangjie Chen
Sisi Zhen
Tingting Zhang
Yuyan Shen
Aiming Pang
Donglin Yang
Rongli Zhang
Qiaoling Ma
Yi He
Jialin Wei

Frontiers in Oncology

doi 10.3389/fonc.2023.1137175

2,904 views
4 citations

Review

Published on 23 Mar 2023

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions

in Hematologic Malignancies

Anna Wolska-Washer
Tadeusz Robak

Frontiers in Oncology

doi 10.3389/fonc.2023.1130595

8,909 views
5 citations

Review

Published on 21 Mar 2023

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future

in Hematologic Malignancies

John Mollstedt
Larry Mansouri
Richard Rosenquist

Frontiers in Oncology

doi 10.3389/fonc.2023.1146486

4,600 views
9 citations

Original Research

Published on 17 Mar 2023

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring

in Hematologic Malignancies

Stefano Vergani
Davide Bagnara
Andreas Agathangelidis
Anita Kar Yun Ng
Gerardo Ferrer
Andrea N. Mazzarello
Florencia Palacios
Sophia Yancopoulos
Xiao-Jie Yan
Jaqueline C. Barrientos

Frontiers in Oncology

doi 10.3389/fonc.2023.1112879

2,982 views
2 citations

Review

Published on 17 Mar 2023

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

in Hematologic Malignancies

Moqin Jiang
Meng Chen
Qian Liu
Zhiling Jin
Xiangdong Yang
Weifeng Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1116438

12,429 views
5 citations

Original Research

Published on 16 Mar 2023

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

in Hematologic Malignancies

Tamara Chitanava
Iuliia Matvienko
Vasily Shuvaev
Sergey Voloshin
Irina Martynkevich
Yulia Vlasova
Elizaveta Efremova
Ekaterina Mileeva
Anna Pirkhalo
Taiana Makarova

Frontiers in Oncology

doi 10.3389/fonc.2023.1138683

1,659 views

Navigation group

Articles

Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis

Effectiveness of pegfilgrastim prophylaxis in preventing febrile neutropenia during R-FC chemoimmunotherapy for chronic lymphocytic leukemia: A multicenter prospective phase II study

Editorial: Advances in the understanding and treatment of cutaneous lymphoma

Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

The RNA helicase DDX3 and its role in c-MYC driven germinal center-derived B-cell lymphoma

Editorial: Inflammation and blood diseases, a dog chasing its tail

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT

Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions

Precision diagnostics in chronic lymphocytic leukemia: Past, present and future

CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoring

SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience